+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Capricor Therapeutics - logo

Capricor Therapeutics focuses on the discovery, development, and commercialization of novel therapeutics primarily for the treatment of cardiovascular diseases. The company's development stage drug candidates for cardiovascular diseases include CAP-1002 and enderitide, which are in Phase II clinical trials. It is also developing Exosomes for the treatment of cardiovascular and non-cardiovascular diseases. The company was founded in 2005 and is headquartered in Beverly Hills, California.

Left Ventricular Dysfunction - Pipeline Insight, 2024 - Product Thumbnail Image

Left Ventricular Dysfunction - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Myocardial Infarction - Pipeline Insight, 2024 - Product Thumbnail Image

Myocardial Infarction - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
From
Exosome Diagnostic and Therapeutic Global Market Report 2024 - Product Thumbnail Image

Exosome Diagnostic and Therapeutic Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Acute Heart Failure Global Clinical Trials Review, H2, 2019 - Product Thumbnail Image

Acute Heart Failure Global Clinical Trials Review, H2, 2019

  • Clinical Trials
  • December 2019
  • 181 Pages
  • Global
From
The Global Market for Stem Cells - Product Thumbnail Image

The Global Market for Stem Cells

  • Report
  • March 2018
  • 162 Pages
  • Global
From
CAP-1002 - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

CAP-1002 - Emerging Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2020 - Product Thumbnail Image

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 770 Pages
  • Global
From
From
Hypovolemic shock - Pipeline Insight, 2024 - Product Thumbnail Image

Hypovolemic shock - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
From
Coronary Artery Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Coronary Artery Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Loading Indicator